Stimulation of tumour angiogenesis by proximal wounds: spatial and temporal analysis by MRI

被引:42
作者
Abramovitch, R [1 ]
Marikovsky, M [1 ]
Meir, G [1 ]
Neeman, M [1 ]
机构
[1] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel
关键词
wound healing; nuclear magnetic resonance imaging; C6 glioma spheroid; tumour growth; angiogenesis;
D O I
10.1038/bjc.1998.70
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We show here, using high-resolution magnetic resonance imaging, that injured tissue provides a favourable milieu for the neovascularization and growth of C6 glioma spheroids, implanted subcutaneously in nude mice. Moreover, the presence of micro-tumours in an injured tissue inhibited the healing process, leaving an open persistent wound. In correlation with the induced angiogenesis of implanted spheroids in the presence of proximal wounds, a shorter lag period was observed for initiation of tumour growth. This effect was restricted spatially and was observed only for wounds within 5 mm from the tumour. In such proximal wounds, angiogenesis was enhanced in the first days after injury, and vessel regression, which normally starts 4 days after injury, did not occur. Injury causing interference to tumour perfusion promoted tumour vascularization and growth even for more remote incisions, possibly by activating stress-induced angiogenesis. The kinetics of vascularization and growth of these wound-tumour systems sheds light on the clinical observations of increased probability of metastatic recurrence and stimulated regrowth of residual tumour in the site of surgical intervention. High-resolution magnetic resonance imaging could detect the aberrant angiogenic activity of these tumour-wound systems as early as 1 week after injury.
引用
收藏
页码:440 / 447
页数:8
相关论文
共 33 条
  • [1] ABRAMOVITCH R, 1995, CANCER RES, V55, P1956
  • [2] ABRAMOVITCH R, 1997, P 5 ISMRM VANC CAN 1, P490
  • [3] VASCULAR ENDOTHELIAL GROWTH-FACTOR ACTS AS A SURVIVAL FACTOR FOR NEWLY FORMED RETINAL-VESSELS AND HAS IMPLICATIONS FOR RETINOPATHY OF PREMATURITY
    ALON, T
    HEMO, I
    ITIN, A
    PEER, J
    STONE, J
    KESHET, E
    [J]. NATURE MEDICINE, 1995, 1 (10) : 1024 - 1028
  • [4] Deelman H T, 1927, Br Med J, V1, P872
  • [5] KERATINOCYTE-DERIVED VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) IS A POTENT MITOGEN FOR DERMAL MICROVASCULAR ENDOTHELIAL-CELLS
    DETMAR, M
    YEO, KT
    NAGY, JA
    VANDEWATER, L
    BROWN, LF
    BERSE, B
    ELICKER, BM
    LEDBETTER, S
    DVORAK, HF
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 105 (01) : 44 - 50
  • [6] DVORAK HF, 1987, LAB INVEST, V57, P673
  • [7] DVORAK HF, 1986, NEW ENGL J MED, V315, P1650
  • [8] FISHER B, 1967, CANCER, V20, P23, DOI 10.1002/1097-0142(1967)20:1<23::AID-CNCR2820200103>3.0.CO
  • [9] 2-P
  • [10] FOLKMAN J, 1992, J BIOL CHEM, V267, P10931